NURECA
Back to All Ratios
|
NURECA Last 5 Year Core EBITDA Margin History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Core EBITDA Margin(%) | -12.87 | 20.55 | 27.36 | 9.75 | 14.20 |
What is the latest Core EBITDA Margin ratio of NURECA ?
Year | Core EBITDA Margin |
---|---|
Mar2023 | -12.87 |
Mar2022 | 20.55 |
Mar2021 | 27.36 |
Mar2020 | 9.75 |
Mar2019 | 14.20 |
How is Core EBITDA Margin of NURECA Trending?
Years | Core EBITDA Margin | % Change | |
---|---|---|---|
Mar2023 | -12.87 | Negative | |
Mar2022 | 20.55 | -24.89 | |
Mar2021 | 27.36 | 180.62 | |
Mar2020 | 9.75 | -31.34 | |
Mar2019 | 14.2 | - |
Other Financial Ratios of NURECA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of NURECA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NURECA | ₹288.6 Cr | -1.6% | 6.9% | -15.1% | Stock Analytics | |
POLY MEDICURE | ₹15,747.5 Cr | 5.4% | 3.6% | 69.4% | Stock Analytics | |
PREVEST DENPRO | ₹492.1 Cr | -6.1% | 21.7% | 25.5% | Stock Analytics |
NURECA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NURECA | -1.6% |
6.9% |
-15.1% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses